BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11229599)

  • 1. Expression of epidermal growth factor and platelet-derived growth factor receptors during cervical carcinogenesis.
    Mayer TJ; Frauenhoffer EE; Meyers AC
    In Vitro Cell Dev Biol Anim; 2000; 36(10):667-76. PubMed ID: 11229599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the platelet-derived growth factor receptor in angiotensin II-induced activation of extracellular regulated kinases 1 and 2 in human mesangial cells.
    Mondorf UF; Geiger H; Herrero M; Zeuzem S; Piiper A
    FEBS Lett; 2000 Apr; 472(1):129-32. PubMed ID: 10781819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of PDGFR and EGFR promotes the acquisition of a stem cell-like phenotype in schwannomas.
    Yi D; Kuo SZ; Zheng H; Abhold EL; Brown CM; Doherty JK; Wang-Rodriguez J; Harris JP; Ongkeko WM
    Otol Neurotol; 2012 Dec; 33(9):1640-7. PubMed ID: 22935817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced receptor expression for platelet-derived growth factor and epidermal growth factor in dividing mouse lung epithelial cells.
    Rice PL; Porter SE; Koski KM; Ramakrishna G; Chen A; Schrump D; Kazlauskas A; Malkinson AM
    Mol Carcinog; 1999 Aug; 25(4):285-94. PubMed ID: 10449035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
    Kommoss F; Colley M; Hart CE; Franklin WA
    Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
    Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
    Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: evidence for down-regulation in cervical cancer.
    Kimmig R; Pfeiffer D; Landsmann H; Hepp H
    Int J Cancer; 1997 Aug; 74(4):365-73. PubMed ID: 9291423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor.
    Liu F; Chernoff J
    Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):139-45. PubMed ID: 9355745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of mRNA for epidermal growth factor receptor and keratin B-2 in normal cervical epithelium and in cervical intraepithelial neoplasia.
    Mittal K; Pearson J; Demopoulos R
    Gynecol Oncol; 1990 Aug; 38(2):224-9. PubMed ID: 1696918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase activity of purified recombinant cytoplasmic domain of platelet-derived growth factor beta-receptor (beta-PDGFR) and discovery of a novel inhibitor of receptor tyrosine kinases.
    Zaman GJ; Vink PM; van den Doelen AA; Veeneman GH; Theunissen HJ
    Biochem Pharmacol; 1999 Jan; 57(1):57-64. PubMed ID: 9920285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal-growth-factor receptor correlates negatively with cell density in cervical squamous epithelium and is down-regulated in cancers of the human uterus.
    Pfeiffer D; Kimmig R; Herrmann J; Ruge M; Fisseler-Eckhoff A; Scheidel P; Jensen A; Schatz H; Pfeiffer A
    Int J Cancer; 1998 Feb; 79(1):49-55. PubMed ID: 9495358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of platelet-derived growth factor receptor in eotaxin signaling of eosinophils.
    Adachi T; Hanaka S; Yano T; Yamamura K; Yoshihara H; Nagase H; Chihara J; Ohta K
    Int Arch Allergy Immunol; 2006; 140 Suppl 1():28-34. PubMed ID: 16772724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors.
    Fleming TP; Saxena A; Clark WC; Robertson JT; Oldfield EH; Aaronson SA; Ali IU
    Cancer Res; 1992 Aug; 52(16):4550-3. PubMed ID: 1322795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressions of c-erbB-2, epidermal growth factor receptor and pan-ras proto-oncogenes in adenocarcinoma of the cervix: correlation with clinical prognosis.
    Leung TW; Cheung AN; Cheng DK; Wong LC; Ngan HY
    Oncol Rep; 2001; 8(5):1159-64. PubMed ID: 11496335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells.
    Herrlich A; Daub H; Knebel A; Herrlich P; Ullrich A; Schultz G; Gudermann T
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8985-90. PubMed ID: 9671791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer.
    Scambia G; Ferrandina G; Distefano M; D'Agostino G; Benedetti-Panici P; Mancuso S
    Cancer Lett; 1998 Jan; 123(2):135-9. PubMed ID: 9489479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
    Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGF and PDGF receptor tyrosine kinases as therapeutic targets for chronic lung diseases.
    Ingram JL; Bonner JC
    Curr Mol Med; 2006 Jun; 6(4):409-21. PubMed ID: 16900664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR).
    Baudhuin LM; Jiang Y; Zaslavsky A; Ishii I; Chun J; Xu Y
    FASEB J; 2004 Feb; 18(2):341-3. PubMed ID: 14657000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.